122 related articles for article (PubMed ID: 8907807)
1. Comparison of chronic neutral endopeptidase inhibition and furosemide in an ovine model of heart failure.
Rademaker MT; Fitzpatrick MA; Charles CJ; Richards AM; Nicholls MG; Espiner EA; Sybertz E
J Cardiovasc Pharmacol; 1996 Mar; 27(3):439-46. PubMed ID: 8907807
[TBL] [Abstract][Full Text] [Related]
2. Acute hemodynamic, hormonal, and renal effects of neutral endopeptidase inhibition in ovine heart failure.
Fitzpatrick MA; Rademaker MT; Charles CJ; Yandle TG; Espiner EA; Ikram H; Sybertz E
J Cardiovasc Pharmacol; 1992 Apr; 19(4):635-40. PubMed ID: 1380608
[TBL] [Abstract][Full Text] [Related]
3. Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure.
Rademaker MT; Charles CJ; Espiner EA; Nicholls MG; Richards AM; Kosoglou T
Clin Sci (Lond); 1996 Sep; 91(3):283-91. PubMed ID: 8869410
[TBL] [Abstract][Full Text] [Related]
4. Concurrent neutral endopeptidase and ACE inhibition in experimental heart failure: renal and hormonal effects.
Helin K
Scand J Clin Lab Invest; 1993 Dec; 53(8):843-51. PubMed ID: 8140395
[TBL] [Abstract][Full Text] [Related]
5. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
[TBL] [Abstract][Full Text] [Related]
6. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
[TBL] [Abstract][Full Text] [Related]
7. Natriuretic peptide analogues with distinct vasodilatory or renal activity: integrated effects in health and experimental heart failure.
Rademaker MT; Scott NJA; Koh CY; Kini RM; Richards AM
Cardiovasc Res; 2021 Jan; 117(2):508-519. PubMed ID: 32167565
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic and hormonal effects of neutral endopeptidase inhibitor SCH 39370 in sheep.
Charles CJ; Espiner EA; Cameron VA; Richards AM; Yandle TG; Sybertz EJ
Hypertension; 1991 May; 17(5):643-51. PubMed ID: 1850715
[TBL] [Abstract][Full Text] [Related]
9. Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failure.
Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
Hypertension; 2002 Jan; 39(1):93-8. PubMed ID: 11799085
[TBL] [Abstract][Full Text] [Related]
10. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
Seymour AA; Asaad MM; Lanoce VM; Langenbacher KM; Fennell SA; Rogers WL
J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922
[TBL] [Abstract][Full Text] [Related]
11. Effect of neutral endopeptidase inhibitor in rats with congestive heart failure.
Murohara Y; Johnston CI
Clin Exp Pharmacol Physiol; 1992 May; 19(5):380-3. PubMed ID: 1325886
[TBL] [Abstract][Full Text] [Related]
12. Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt.
Willenbrock R; Scheuermann M; Höhnel K; Luft FC; Dietz R
Hypertension; 1996 Jun; 27(6):1259-66. PubMed ID: 8641733
[TBL] [Abstract][Full Text] [Related]
13. Enhanced natriuretic response to neutral endopeptidase inhibition in heart-transplant recipients.
Geny B; Hardy H; Lonsdorfer J; Eisenmann B; Haberey P; Piquard F
Hypertension; 1999 Apr; 33(4):969-74. PubMed ID: 10205232
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure.
Seymour AA; Asaad MM; Lanoce VM; Fennell SA; Cheung HS; Rogers WL
Cardiovasc Res; 1993 Jun; 27(6):1015-23. PubMed ID: 8221758
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of Natriuretic Peptide Bioactivity via Combined Inhibition of Neprilysin and Phosphodiesterase-9 in Heart Failure.
Scott NJA; Prickett TCR; Charles CJ; Frampton CM; Richards AM; Rademaker MT
JACC Heart Fail; 2023 Feb; 11(2):227-239. PubMed ID: 36752488
[TBL] [Abstract][Full Text] [Related]
16. Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep.
Charles CJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG; Protter A; Kosoglou T
Am J Physiol; 1996 Aug; 271(2 Pt 2):R373-80. PubMed ID: 8770137
[TBL] [Abstract][Full Text] [Related]
17. Prolonged neutral endopeptidase inhibition in heart failure.
Helin K; Tikkanen I; Tikkanen T; Saijonmaa O; Sybertz EJ; Vemulapalli S; Sariola H; Fyhrquist F
Eur J Pharmacol; 1991 May; 198(1):23-30. PubMed ID: 1655477
[TBL] [Abstract][Full Text] [Related]
18. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
Richards AM; Crozier IG; Espiner EA; Ikram H; Yandle TG; Kosoglou T; Rallings M; Frampton C
J Cardiovasc Pharmacol; 1992; 20(5):735-41. PubMed ID: 1280735
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic and neuroendocrine effects for candoxatril and frusemide in mild stable chronic heart failure.
Westheim AS; Bostrøm P; Christensen CC; Parikka H; Rykke EO; Toivonen L
J Am Coll Cardiol; 1999 Nov; 34(6):1794-801. PubMed ID: 10577572
[TBL] [Abstract][Full Text] [Related]
20. [Plasma levels of brain natriuretic peptide, cyclic 3'5'-guanosine monophosphate, endothelin 1, and noradrenaline in patients with chronic congestive heart failure].
Salomon P; Przewłocka-Kosmala M; Orda A
Pol Arch Med Wewn; 2003 Jan; 109(1):43-8. PubMed ID: 12879765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
